Patient Satisfaction and Recovery Outcomes Associated With Perioperative ELIXIR MD Use

Part of paid clinical trials in Irvine, California.

Sponsor
Elixir MD Inc
Study ID
NCT07311889
Status
Enrolling By Invitation

Conditions

  • Postoperative Ecchymosis
  • Postoperative Edema
  • Postoperative Pain
  • Postsurgical Recovery
  • Surgical Wound Healing

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Perioperative photobiomodulation light therapy — OTHER
    Participants may receive perioperative light therapy as part of routine clinical care at the discretion of their treating clinician. The study does not assign, modify, or mandate the use of light therapy. Data are collected observationally to describe recovery outcomes associated with standard clinical practice.

Study Details

The goal of this observational registry study is to characterize postoperative recovery outcomes in adult patients receiving standard-of-care perioperative light therapy using an FDA-cleared photobiomodulation device as part of routine clinical practice. The study aims to describe changes in patient-reported and clinician-assessed recovery measures following elective surgical procedures. The main questions this registry aims to answer are: 1. How do patient-reported recovery outcomes, including pain, satisfaction, and perceived improvement, change over the postoperative period? 2. How do clinician-assessed indicators of recovery, such as swelling and bruising, change over time following surgery? This study does not include a randomized comparison group. Outcomes will be described longitudinally within participants based on data collected during routine care. Participants will: 1. Receive perioperative light therapy as part of standard clinical care, per their treating clinician 2. Complete patient-reported outcome questionnaires at defined postoperative time points 3. Undergo standardized clinical photography and routine clinical assessments as part of usual follow-up

Key Dates

Start date
Jan 19, 2026
Status verified
Dec 2025
Primary completion
Jun 1, 2026
Completion
Jul 1, 2026

Study Design

Enrollment
300 participants (estimated)

Primary Outcome Measure

Patient-reported satisfaction with postoperative recovery [ Time Frame: From baseline (preoperative) through 10 days postoperatively ]

Locations (1)

FacilityCityStateZIPSite coordinators
ELIXIR MD IncIrvineCalifornia92612-

Find similar trials in Irvine, CA

By research site
ELIXIR MD Inc· Irvine, CA

Related Studies